Skip to content

AbCellera Biologics Inc. ABCL CA-BC — Accrued grants receivable

Similar metrics at other companies

SHA
SHAZGrants receivable
$891.48K
Construction Partners logo
ROADAccrued revenue share
$515.65M+26.0%
Golub Capital logo
GBDCAccrued interest receivable
$63.68M-3.1%
Capricor Therapeutics logo
CAPRReceivable from credits from ARPA
$0-100%
Eos Energy Enterprises, Inc. logo
EOSEIncrease (Decrease) In Grant Receivable
$10.34M+475%
Protagonist Therapeutics logo
PTGXAccrued revenue share
$53.66M

Other financials

Income statement

See full
Revenue$8.3M+96.3%
Operating income-$57.5M+8.2%
Net income-$43.2M+5.4%
EPS (diluted)-$0.14+6.7%

Balance sheet

See full
Cash & equivalents$102.1M-44.6%
Total debt$140.2M+107%
Total equity$938.1M-8.3%
Total assets$1.3B-2.8%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$3.8M-64.0%
Free cash flow-$37.4M-68.3%

Valuation

See full
Market cap$1.84B+59.2%
Enterprise value$1.88B+100.0%
P/S23.3×-26.8×

Profitability

See full
Operating margin-267.6%-120pp
Net margin-181.7%-77.9pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-14.7%-0.8pp
Debt / equity0.1×+0.1×
Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept abcl:GovernmentAssistanceAccruedGrantsReceivableAmount.

The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s ca-bc — accrued grants receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbCellera Biologics Inc.'s CA-BC — accrued grants receivable?
AbCellera Biologics Inc. (ABCL) reported CA-BC — accrued grants receivable of $17.7M in Q1 2026.
What does CA-BC — accrued grants receivable mean?
Represents the amount of grant funding earned by the CA-BC segment for which the company has met the necessary performance criteria but has not yet received the cash payment. It serves as a measure of earned but unrealized government-backed revenue.